Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial

The Lancet Neurology

Volumn 9, Issue 6, 2010, Pages 581-591

  Williams, Adrian ^a   Gill, Steven ^b   Varma, Thelekat ^c   Jenkinson, Crispin ^d   Quinn, Niall ^e   Mitchell, Rosalind ^a   Scott, Richard ^f   Ives, Natalie ^g   Rick, Caroline ^g   Daniels, Jane ^g   Patel, Smitaa ^g   Wheatley, Keith ^g  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; APOMORPHINE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT;

ADULT; AGED; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; DISEASE PROGRESSION; DYSKINESIAS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952320903     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70093-4     Document Type: Article

References (36)

1. Williams D., Tijssen M., van Bruggen G., et al. Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain 125 (2002) 1558-1569
2. Poewe W. Treatments for Parkinson disease-past achievements and current clinical needs. Neurology 72 7 Suppl (2009) S65-S73
3. Mitchell I.J., Clarke C.E., Boyce S., et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 32 (1989) 213-226
4. Bergman H., Wichmann T., and DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249 (1990) 1436-1438
5. Aziz T.Z., Peggs D., Sambrook M.A., and Crossman A.R. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 6 (1991) 288-292
6. Limousin P., Krack P., Pollak P., et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 339 (1998) 1105-1111
7. Stowe R.L., Wheatley K., Clarke C.E., et al. Surgery for Parkinson's disease: lack of reliable clinical trial evidence. J Neurol Neurosurg Psychiatry 74 (2003) 519-521
8. Gibb W.R.G., and Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51 (1988) 745-752
9. Mattis S. Dementia rating scale: professional manual (1988), Psychological Assessment Resources, Odessa, FL, USA
10. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 (1967) 427-442
11. Daniels J., Wheatley K., and Gray R. Pairwise randomisation to balance within centres without possible foreknowledge of allocation. Control Clin Trials 24 suppl 3S (2003) 104S-105S (abstract P23).
12. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., and Hyman N. The Parkinson's disease questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 26 (1997) 353-357
13. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The unified Parkinson's disease rating scale (UPDRS): status and recommendations. Mov Disord 18 (2003) 738-750
14. Scott R.B., Farmer E., Smiton A., Tovey C., Clarke M., and Carpenter K. Methodology of neuropsychological research in multicentre randomized clinical trials: a model derived from the International Subarachnoid Aneurysm Trial. Clin Trials 1 (2004) 31-39
15. Jenkinson C., Hefferman C., Doll H., and Fitzpatrick R. The Parkinson's disease questionnaire (PDQ-39): evidence for a method of imputing missing data. Age Ageing 35 (2006) 497-502
16. Deuschl G., Schade-Brittinger C., Krack P., et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 355 (2006) 896-908
17. Weaver F.M., Follett K., Stern M., et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson's disease: a randomized controlled trial. JAMA 301 (2009) 63-73
18. Goetz C.G., Wuu J., McDermott M.P., et al. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord 23 (2008) 690-699
19. Schüpbach W.M., Maltête D., Houeto J.L., et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 68 (2007) 267-271
20. Peto V., Jenkinson C., and Fitzpatrick R. Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire. Age Ageing 30 (2001) 299-302
21. Schrag A., Sampaio C., Counsell N., and Poewe W. Minimal clinically important change on the unified Parkinson's disease rating scale. Mov Disord 21 (2006) 1200-1207
22. Kleiner-Fisman G., Herzog J., Fisman D.N., et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 21 (2006) S290-S304
23. Weaver F., Follett K., Hur K., Ippolito D., and Stern M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. J Neurosurg 103 (2005) 956-957
24. Lanotte M.M., Rizzone M., Bergamasco B., Faccani G., Melcarne A., and Lopiano L. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 72 (2002) 53-58
25. Starr P.A., Christine C.W., Theodosopoulos P.V., et al. Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 97 (2002) 370-387
26. Hariz M.I., Rehncrona S., Quinn N.P., Speelman J.D., Wensing C., and Multicentre Advanced Parkinson's Disease Deep Brain Stimulation Group. Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years. Mov Disord 23 (2008) 416-421
27. Appleby B.S., Duggan P.S., Regenberg A., and Rabins P.V. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov Disord 22 (2007) 1722-1728
28. Burkhard P.R., Vingerhoets F.J., Berney A., Bogousslavsky J., Villemure J.G., and Ghika J. Suicide after successful deep brain stimulation for movement disorders. Neurology 63 (2004) 2170-2172
29. Voon V., Krack P., Lang A.E., et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131 (2008) 2720-2728
30. Contarino M.F., Daniele A., Sibilia A.H., et al. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 78 (2007) 248-252
31. Parsons T.D., Rogers S.A., Braaten A.J., Woods S.P., and Tröster A.I. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 5 (2006) 578-588
32. Scott R., Gregory R., Hines N., et al. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease-a consecutive series of eight simultaneous bilateral and twelve unilateral procedures. Brain 121 (1998) 659-675
33. Cilia R., Siri C., Marotta G., et al. Brain networks underlining verbal fluency decline during STN-DBS in Parkinson's disease: an ECD-SPECT study. Parkinsonism Relat Disord 13 (2007) 290-294
34. Wojtecki L., Timmermann L., Jorgens S., et al. Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol 63 (2006) 1273-1276
35. Assmann S.F., Pocock S.J., Enos L.E., and Kasten L.E. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 355 (2000) 1064-1069
36. Sutton A.J., Abrams K.R., Jones D.R., Sheldon T.A., and Song F. Methods for meta-analysis in medical research (2000), John Wiley and Sons Ltd, Chichester, UK